This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignee: University of California. Active years: 2012-2014.
Company Filing History:
Years Active: 2012-2014
Title: Karyn Newman: Innovator in Isoprenoid Modifying Enzymes
Introduction
Karyn Newman is a prominent inventor based in Berkeley, CA (US). She has made significant contributions to the field of biotechnology, particularly in the area of isoprenoid modifying enzymes. With a total of 3 patents to her name, her work has implications for both agricultural and microbial health.
Latest Patents
One of her latest patents is titled "Polynucleotides encoding isoprenoid modifying enzymes and methods of use thereof." This invention provides isolated nucleic acids that comprise nucleotide sequences encoding isoprenoid modifying enzymes. It also includes recombinant vectors containing these nucleic acids and genetically modified host cells that utilize them. Furthermore, the invention outlines methods for producing isoprenoid compounds through the cultivation of genetically modified host cells.
Another significant patent focuses on "Biological control of pathogenicity in microbes that use alpha, beta unsaturated fatty acid signal molecules." This patent describes methods and compositions for controlling diseases caused by pathogenic microbes that express these signal molecules. The method involves inoculating a host organism with a non-pathogenic microbe that disrupts the communication between pathogenic microbes, thereby controlling the disease.
Career Highlights
Karyn Newman has established herself as a leading figure in her field through her innovative research and patent contributions. Her work at the University of California has allowed her to explore the genetic modifications that can lead to advancements in both plant and microbial health.
Collaborations
Throughout her career, Karyn has collaborated with notable colleagues such as Dae-Kyun Ro and Eric M Paradise. These partnerships have further enhanced her research and contributed to the success of her inventions.
Conclusion
Karyn Newman is a trailblazer in the field of biotechnology, with her patents paving the way for advancements in isoprenoid modifying enzymes and microbial health. Her contributions continue to impact the scientific community and hold promise for future innovations.